Evidence map›Paper›PMID 40108278›Full record

ArticleScientific reports2025

Ovarian cryopreservation with rapamycin improves fertility restoration in a murine orthotopic transplantation model.

Jules Bindels, Marlyne Squatrito, Laëtitia Bernet, Michelle Nisolle, Carine Munaut

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Cryopreservation of Rodent Ovarian Tissues and Oocytes.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jules BindelsLaboratory of Biology of Tumor and Development, GIGA-Cancer, Université de Liège, 4000, Liège, Belgium.
Marlyne SquatritoLaboratory of Biology of Tumor and Development, GIGA-Cancer, Université de Liège, 4000, Liège, Belgium.
Laëtitia BernetLaboratory of Biology of Tumor and Development, GIGA-Cancer, Université de Liège, 4000, Liège, Belgium.
Michelle NisolleDepartment of Obstetrics and Gynecology, Hôpital de la Citadelle, Université de Liège, 4000, Liège, Belgium.
Carine MunautLaboratory of Biology of Tumor and Development, GIGA-Cancer, Université de Liège, 4000, Liège, Belgium. c.munaut@uliege.be.

Funding

Fonds de la Recherche Scientifique (F.R.S.-FNRS, Belgium) 7.6504.22, J.0156.20, and J.0143.22Foundation Léon Fredericq (University of Liège) 2022-186University of Liège FRS-F-2022-FM and FRS-F-2023-FM
6 · The paper itself

Abstract

Currently, the only fertility preservation option of prepubertal patients is ovarian tissue cryopreservation followed by autotransplantation (OTCTP). Once in remission and patients desire to conceive, autotransplantation of frozen/thawed tissue is performed. A major issue of this technique is follicular loss directly after transplantation, mainly due to follicle activation. Our previous research showed that adding rapamycin to the freezing medium counteracted follicle proliferation and activation induced by OTCTP in heterotopic autotransplantation of ovaries in mice. Our current study aimed to test the potential of this approach to improve fertility restoration in mice. Forty 4-week-old female C57BL/6 mice underwent unilateral oophorectomy followed by slow-freezing of ovaries with or without rapamycin. After chemically disabling the remaining ovary, orthotopic autotransplantation was performed. After recovery, estrous cycle analysis was conducted using daily vaginal smears. The mice were mated with males for 4 months, and pregnancy outcomes were recorded. After mating, half the females were super-ovulated for oocyte quantification and ovarian analysis, while the others had their ovaries collected for analysis of remaining primordial follicles using immunohistochemistry. Female mice whose ovaries were cryopreserved with rapamycin prior to chemically disabling the remaining ovary and orthotopic autotransplantation, gave birth to more pups (102 rapamycin, 48 control). The live birth rate was also higher (P = 0.0025) when ovaries were cryopreserved in rapamycin compared to control medium. Additionally, more mice in the rapamycin group gave birth (13 rapamycin, 8 control) with a higher average litter size (P = 0.0837). More mice had primordial follicles left at the end of the experiment in the rapamycin group (P = 0.0397). Superovulation showed a similar number of oocytes collected (P = 0.4462). While rapamycin did not influence cyst formation after autotransplantation, mice that developed ovarian cysts gave birth to fewer pups per dam (P = 0.0119) with a lower live birth rate compared to mice without ovarian cysts (P = 0.0032). The use of rapamycin improved fertility restoration in mice. Using rapamycin during OTCTP in humans could potentially resolve the massive follicular loss directly after grafting, and thus eventually lead to better opportunities for women to become pregnant.

Indexed as

CryopreservationFertilityFertility PreservationOvarySirolimusAnimalsFemaleMaleMiceMice, Inbred C57BLOocytesOvarian FolliclePregnancyTransplantation, AutologousSirolimusAnimal modelsFertility preservationFollicle activationOvarian cryopreservationOvarian transplantationRapamycin

Identifiers

PMID40108278
PMCPMC11923166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.